New insider activity at Natera ( (NTRA) ) has taken place on November 26, 2025.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Director Roelof Botha recently executed a significant transaction involving Natera stock, selling 73,000 shares. This sale amounted to a substantial $17,250,679, marking a notable financial move within the company.
Recent Updates on NTRA stock
In the last 24 hours, several financial firms have raised their price targets for Natera’s stock, reflecting positive sentiment following the company’s recent performance. JPMorgan increased its price target to $250, citing updates to the company’s model. UBS raised its target to $280, maintaining a Buy rating, while Stephens increased its target to $235, highlighting Natera as a compelling organic growth story within diagnostics after a strong earnings report. Morgan Stanley also raised its target to $220, maintaining an Overweight rating. These adjustments are largely driven by Natera’s strong Q3 growth and raised guidance, indicating robust future prospects.
Spark’s Take on NTRA Stock
According to Spark, TipRanks’ AI Analyst, NTRA is a Neutral.
Natera’s overall stock score is driven by strong earnings call results and positive technical analysis, indicating robust growth and market momentum. However, financial performance challenges and valuation concerns due to ongoing losses and a negative P/E ratio temper the overall score.
To see Spark’s full report on NTRA stock, click here.
More about Natera
YTD Price Performance: 47.25%
Average Trading Volume: 1,307,561
Technical Sentiment Signal: Buy
Current Market Cap: $32.64B